Ticker Symbol: ATHE
Alterity Therapeutics Ltd - ADR
$1.12 - 20-12-2024 4 p.m. ET
Exchange: NASDAQ
Country:
Australia
Currency:
USD
Asset
Type: ADR
CIK:0001131343
Company Profile
alterity therapeutics limited researches and develops therapeutic drugs for the treatment of parkinsonian's disease and other neurodegenerative diseases in australia. the company's lead drug candidates is ath434 that has completed phase i clinical trial for the treatment of parkinson's disease. it is also developing pbt2 for used as an antimicrobial agent. the company was formerly known as prana biotechnology limited and changed its name to alterity therapeutics limited in april 2019. the company was founded in 1997 and is based in melbourne, australia.
Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
Standard Industrial Classification Code (SIC code): 2834
Address: L 3 460 Bourke St
Website: http://pranabio.com/
CEO: Geoffrey Kempler
Tags:
- Biotechnology
- Health Technology
Pricing
Last Updated: December 31, 1969 07:00 PM EST
Previous Close: -
Change:
$0.04
(
1.68%)
Days Range: $2.38 - $2.42
Beta: -
52wk. High: $4.50
52wk. Low: $2.10
Ytd. Change -28.82%
50 Day Moving Average: $2.58
200 Day Moving Average: $2.77
Shares Outstanding: 4066496
Valuation
Market Cap: 984.1M
PE Ratio: -
EPS (TTM): 0
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A